Skip to content
Unrated Drug recall · FDA · Published March 1, 2019

Legacy Pharmaceutical Losartan Tablets Recall: Impurity Risk

Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets (50mg) due to detected impurity NMBA. Affected lots: 180190, 180191 (exp 10/2020) and 181597 (exp 02/2021).

🇺🇸 FDA recall #D-1075-2019DrugLegacy Pharmaceutical Packaging LLC ›
Take action

Contact the company

Recalling firmLegacy Pharmaceutical Packaging LLC13333 Lakefront Dr · Earth City, MO 63045-1514
✎ GovInfoNow plain-language explainer

What happened, in plain English

Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets (50mg) because they contain an impurity called NMBA. This impurity could pose a health risk to people taking the medication. Read more at govinfonow.com/recall/39135-legacy-pharmaceutical-losartan-tablets-recall-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39135-legacy-pharmaceutical-losartan-tablets-recall-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1075-2019

Cite this page

“Legacy Pharmaceutical Losartan Tablets Recall: Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39135-legacy-pharmaceutical-losartan-tablets-recall-impurity-risk. Based on FDA recall #D-1075-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1075-2019%22&limit=1).

Why it’s dangerous

The recall is due to the presence of an impurity called N-Methylnitrosobutyric acid (NMBA) in the medication. While the exact health risk isn't specified in the recall, impurities in medications can sometimes cause adverse reactions.

Who’s affected

People who have prescription Losartan Potassium Tablets (50mg) from Legacy Pharmaceutical Packaging LLC. Those with the specific lots mentioned are most at risk.

How to tell if you have this one

Check your prescription bottle for the product name 'Losartan Potassium Tablets, USP, 50 mg, 30 tablets'. Look for the lot numbers 180190, 180191 (expiring 10/2020) or 181597 (expiring 02/2021).

  • Brand
    Legacy Pharmaceutical Packaging LLC
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify your bottle by checking the product name and lot numbers listed above.

Where it went and when

Where it was distributed

Distributed in 3 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: yesINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “AZ, IN, TN” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona, Indiana, Tennessee.

Recall timeline

FDA terminated this recall 4.6 years after the firm started it.

1. Firm started the recall: Mar 1, 201912. FDA classified it Class II: Apr 1, 201923. Published in FDA’s Enforcement Report: Apr 10, 201934. FDA terminated the recall: Sep 29, 2023420192023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1075-2019 (March 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1075-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA